Activating monoclonal antibodies using ultraviolet light allowed British scientists to kill tumors in five of six mice with ovarian cancer without harming healthy tissues. Researchers "cloaked" the antibodies with a light-sensitive organic oil, stopping the antibodies until they came into contact with light. Then the researchers activated them by shining UV light at the tumor site.

Full Story:

Related Summaries